| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1.2 | 0.8 |
| Gross profit | 0.1 | -0.1 |
| Profit before tax | -1.9 | -0.7 |
| Net income | -1.9 | -0.7 |
| EPS (diluted, $ a share) | $-0.04 | $-0.17 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +52.5% |
|---|---|
| Gross margin | 8.0% |
| Operating margin | -162.8% |
Source
Read the filing ↗
10-Q filed with the SEC, NYSE: CPHI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
China Pharma Holdings, Inc.: key numbers
- Share price
- $0.5109Close, Nov 18
- Market cap
- $22M
- Shares outstanding
- 43.02MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.